Pulmonary function tests showed a forced expiratory volume in 1 s (FEV 1 )/forced vital capacity of 48.41%, FEV 1 of 1.37 L (41.9% of predicted), maximum ventilatory volume of 50.1 L/min (49.4%), revealing persistent airflow limitation, even when he was in stable. The bronchial test revealed positive. Using GINA or GOLD guidelines, his diagnosis was consistent with ACOS. He had ACOS exacerbations triggered by upper respiratory tract infections once a year, and corticosteroids pulses were frequently administered. He has no other past history except ACOS.
On admission, the temperature was 38.8°C, pulse 80 beats/min; blood pressure 135/80 mmHg; respiratory rate, 20 breaths/min. There was dullness to percussion of the upper right lung, diminished breath sounds and rales in both lungs. He had a decreased CD3 + T-cell (490/mm 3 , % predicted 50%), a CD4 + T-cell (118/mm 3 , % predicted 12%). Acid-fast bacilli smear test was negative. Blood and sputum cultures both grew methicillin-resistant coagulase-negative Staphylococcus. Blood beta-D-glucan was significantly elevated (2580 pg/ml), as well as galactomannan (2.66 pg/ml).
The specific and total serum immunoglobulin E for Aspergillus was normal. On October 2009, chest computed tomography scans [ Figure 1a and b] showed new right greater than left upper lobe infiltrates with the cavitary lesion formation.
The patient was treated empirically for asthma with IV methylprednisolone (40 mg, qd), inhaled budesonide, salbutamol, ipratropium bromide. Linezolid and imipenem were used for an anti-infection therapy. Meanwhile, the patient was commenced on IV itraconazole (ITR) (250 mg/d). On day 5 of the treatment, he defervesced. Neither acid-fast bacilli nor bacteria were detected. However, sputum culture still grew Aspergillus fumigatus. ACOS-related deficiencies in the airway epithelial barrier create a higher opportunity for Aspergillus colonization. [1] Meanwhile,
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systemic corticosteroids pulse also disposes the patient to IPA. [2, 3] Treatment for IPA remains difficult, and prompt administration of antifungal agents should be considered after a clinical suspicion of IPA. VRZ is now indicated as a standard antifungal therapy. CAS is approved as salvage therapy after intolerance or failure of conventional antifungal therapy. For the combination therapy, no enough evidence supported as primary therapy, but it can act as a salvage antifungal therapy that supported by many studies reported a decrease in mortality in IPA. [4] In this case, the patient started with ITR as primary therapy since VRZ was not covered by the medical insurance in China. Due to the unsatisfied effect of 1-month single-antifungal therapy with ITR, we changed to the combination therapy with both VRZ and CAS. Conclusively, in this case, the unique mechanisms of combination therapy provided clinical benefits for the refractory IPA. For ACOS control, the GOLD guideline recommends that it is prudent to start treatment as for asthma until further investigation has been performed to confirm the COPD diagnosis. If COPD was assessed, treatment with bronchodilators or combination therapy was suggested. The patient has severe asthma.
Treatment during stable periods is inhaled corticosteroid/long-acting beta-agonist. However, due to combined COPD, the long-acting muscarinic antagonist was added to control the symptoms.
Surgery of an IPA focus is seldom used in ACOS patients due to the poor pulmonary function. However, in this case, the role of surgical lung resection cannot be ignored. While antifungal therapy is essential for IPA, often there is reduced lung tissue penetration, particularly notable with ITR, and residual lesions are often present. [5] Surgeries can potentially eradicate localized infection and simultaneously provide both a definitive diagnosis of IPA. In this case, negative fungus result was achieved in the first sputum culture after surgery, suggested that the surgery scavenged the majority of Aspergillus spp., thus reduced secondary dissemination. Besides, right upper lobectomy made intractable pneumothorax curable. 
